LAMEA Shoulder Arthroplasty Market Analysis (2017-2023)
Special Offering : Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The LAMEA Shoulder Arthroplasty Market would witness market growth of 9.5% CAGR during the forecast period (2017-2023). Shoulder arthroplasty or shoulder replacement is a surgical procedure used in the replacement of damaged ball and socket joint which is located in the shoulder. The surgical procedure is conducted using prosthesis, and it usually consists of polythene and metal components. Shoulder arthroplasty is a preferred modality and it is used in the treatment of osteoarthritis, rheumatoid arthritis, and osteonecrosis, as the procedures used have yielded great and reproducible results. The growth of the LAMEA shoulder arthroplasty market is driven due to factors such as increasing incidences of arthritis-associated disorders such as osteoarthritis and rheumatoid arthritis, and growing geriatric population. Also, significant adoption of reverse shoulder arthroplasty by surgeons and growing sports-related injuries have further contributed to the growth of the market.
The shoulder arthroplasty market is segmented based on procedures, devices, indications, end users, and regions. Based on procedures, the market is segmented into partial shoulder arthroplasty, total shoulder arthroplasty, and revision shoulder arthroplasty. Based on devices, the market is segmented into shoulder arthroplasty resurfacing implants, shoulder arthroplasty trauma devices, and shoulder arthroplasty platform systems. Based on indications, the market is segmented into arthritis, fracturedislocation, rotator cuff tear arthropathy, Hill Sachs defect, and others. Based on end users, the market is segmented into hospitals & clinics and outpatient surgical centers. Based on geography, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA. The market research report covers the analysis of key stake holders of the LAMEA Shoulder Arthroplasty Market.
Key companies profiled in the report include Integra LifeSciences Corporation, DJO Global, Zimmer Biomet, Wright Medical Group, Inc. Tornier Inc., Johnson & Johnson (DePuy Synthes), Smith and Nephew Plc, Arthrex, Inc., Conmed Corporation, Evolutis, and Exactech, Inc.